Frequency Therapeutics, Inc. (FREQ)

NASDAQ: FREQ · IEX Real-Time Price · USD
1.54
+0.01 (0.65%)
At close: Jul 6, 2022 4:00 PM
1.55
+0.01 (0.65%)
After-hours: Jul 6, 2022 6:04 PM EDT

Balance Sheet (Quarterly)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ended 2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Cash & Equivalents
51.5381.33113.76136.85171.05222.16226.05197.19204.89200.26142.27--42.19-17.94
Short-Term Investments
67.5351.0736.0433.8725.680003.0217.223.05--0-0
Cash & Cash Equivalents
119.06132.41149.8170.71196.73222.16226.05197.19207.92217.46165.320042.19017.94
Cash Growth
-39.48%-40.40%-33.73%-13.43%-5.38%2.16%36.73%--415.43%------
Other Current Assets
0.882.340.111.653.352.91.31.242.033.91.4--0.75-0.02
Total Current Assets
119.94134.75149.91172.36200.08225.06227.34198.42209.94221.36166.72--42.94-17.96
Property, Plant & Equipment
35.5736.8738.1539.3939.6137.845.164.553.981.761.57--1.51-1.73
Long-Term Investments
7.4111.7212.46.640000000--0-0
Other Long-Term Assets
2.032.021.731.831.821.821.821.811.80.12.56--0.1-0.1
Total Long-Term Assets
4550.6152.2847.8541.4339.666.986.365.781.864.13--1.61-1.83
Total Assets
164.94185.36202.19220.21241.51264.72234.32204.79215.72223.22170.85--44.55-19.79
Accounts Payable
2.252.753.613.895.455.514.092.192.651.2219.57--1.86-0.99
Deferred Revenue
00009.4214.0724.0235.2743.7951.0555.76--0-0
Current Debt
5.152.581.681.621.30.40.430.420.4100--0-0
Other Current Liabilities
4.786.15.23.532.756.664.383.29-3.120.51-3.13--1.91-1.23
Total Current Liabilities
12.1711.4310.499.0318.9226.6332.9241.1743.7352.7872.2--3.77-2.23
Long-Term Debt
40.0443.0244.3144.7545.1945.61.811.922.0300--0-0
Other Long-Term Liabilities
0.060.090.280.3900005.113.086.62--0.35-0.51
Total Long-Term Liabilities
40.143.1144.5845.1445.1945.61.811.927.143.086.62--0.35-0.51
Total Liabilities
52.2754.5355.0754.1764.172.2334.7343.0950.8755.8678.83--4.12-2.74
Total Debt
45.1945.645.9946.3746.4845.992.242.342.4400--0-0
Debt Growth
-2.79%-0.86%1952.08%1880.69%1804.22%-----------
Common Stock
316.44310.97305.7299.46293.17287.86284.72241.47238.67236.19-0.1900-2.9700.28
Retained Earnings
-203.47-180.09-158.59-133.43-115.77-95.4-85.17-79.83-73.8-68.89-63.36---49.09--29.92
Comprehensive Income
-0.3-0.0600.010.010.030.040.06-0.020.050.12--0-0
Shareholders' Equity
112.67130.82147.12166.04177.41192.49199.59161.7164.85167.36-63.43---52.06--29.64
Total Liabilities and Equity
164.94185.36202.19220.21241.51264.72234.32204.79215.72223.2215.400-47.930-26.91
Net Cash / Debt
73.8786.81103.81124.35150.25176.17223.81194.85205.48217.46165.320042.19017.94
Net Cash / Debt Growth
-50.83%-50.72%-53.61%-36.18%-26.88%-18.99%35.38%--415.43%------
Net Cash Per Share
2.122.513.013.634.405.216.776.276.6625.1476.42--24.95-25.52
Working Capital
107.77123.32139.42163.33181.16198.43194.42157.26166.21168.5894.52--39.16-15.73
Book Value Per Share
3.243.784.274.855.205.696.045.215.3419.35-29.32---30.79--42.17
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).